ArticleBreast cancer research : BCR2025

Prevalence and concordance of HER2-low and HER2-ultralow status between historical and rescored results in a multicentre study of breast cancer patients in China.

Hong Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.